fluorobenzenes has been researched along with Hepatic Failure in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albertson, TE; Bernard, GR; Brower, RG; deBoisblanc, BP; Douglas, IS; Hite, RD; Hough, CL; Liu, KD; Matthay, MA; Rock, P; Shanholtz, C; Steingrub, J; Thompson, BT; Truwit, JD | 1 |
1 trial(s) available for fluorobenzenes and Hepatic Failure
Article | Year |
---|---|
Rosuvastatin for sepsis-associated acute respiratory distress syndrome.
Topics: Adult; Aged; Creatine Kinase; Double-Blind Method; Female; Fluorobenzenes; Hospital Mortality; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver Failure; Male; Middle Aged; Pyrimidines; Renal Insufficiency; Respiratory Distress Syndrome; Rosuvastatin Calcium; Sepsis; Sulfonamides; Survival Analysis; Treatment Failure | 2014 |